About Us
Suzhou Evermed Biomedical Co., Ltd., founded in 2012 and located in the Jiangsu Medical Device Technology Industrial Park, is a national high-tech enterprise specializing in the R&D, production, sales, and after-sales services of clinical in vitro diagnostic (IVD) reagents and the corresponding analyzers.
Our scientists at Evermed are highly skilled in leveraging our in-house developed and commercial antibodies to create a diverse array of immunoassays. Our current portfolio of immunoassays encompasses Homogeneous Enzyme Immunoassays (HEIA), Chemiluminescence Immunoassays (CLIA), Fluorescence Immunoassays (FIA), Turbidimetric Immunoassays (TIA), and Microparticle Enhanced Immunoassays (MPIA).
Evermed remains dedicated to high-end specialized testing and continuous innovation. Our self-developed and produced series of test kits, including urine hormone and therapeutic drug monitoring (TDM) kits, offer clinical advantages such as automation, high throughput, systematization, and user-friendliness. These products precisely support hypertension prevention and control, as well as personalized medication in China, filling gaps in the domestic market.
Evermed is committed to addressing real clinical challenges and consistently meeting practical clinical needs. Through relentless dedication and perseverance, we strive to contribute to the high-quality development of the clinical in vitro diagnostics industry and to the health and well-being of the people.
We enjoy a close partnership with SJK Global LLC in US to manufacture, distribute, and service our products in US, Europe, and many other regions outside of China.